Docdemic

ICD-10 diagnosis code

T80.8 Other complications following infusion, transfusion and therapeutic injection

This page in Swedish

T80.8 is the ICD-10 code for Other complications following infusion, transfusion and therapeutic injection. It is a four-character subcategory of T80 (Complications following infusion, transfusion and therapeutic injection), the most specific level in the WHO edition. It belongs to the block T80–T88 (Complications of surgical and medical care, not elsewhere classified) in Chapter XIX, Injury, poisoning and certain other consequences of external causes.

Code type
Subcategory (4 characters)
Chapter
XIX · S00–T98
Classification
WHO ICD-10, 2019 version

T80.8 in national editions

Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.

SwedenICD-10-SE

T80.8Andra specificerade komplikationer som följd av infusion, transfusion och injektion i behandlingssyfte

NorwayICD-10-NO

T80.8Annen spesifisert komplikasjon etter infusjon, transfusjon eller terapeutisk injeksjon

DenmarkICD-10-DK

DT808Anden komplikation efter infusion, transfusion eller injektion

  • DT808AHæmoglobinæmi efter transfusion
  • DT808BHæmosiderose efter transfusion
  • DT808CKomplikation efter spinal eller epidural anæstesi UNS
  • DT808EEkstravasation af kemoterapeutikum
FinlandICD-10-FI

T80.8Muu määritetty komplikaatio infuusion, transfuusion tai hoitotarkoituksessa annetun injektion jälkeen

GermanyICD-10-GM

T80.8Sonstige Komplikationen nach Infusion, Transfusion oder Injektion zu therapeutischen Zwecken

FranceICD-10-FR

T80.8Autres complications consécutives à une injection thérapeutique, une perfusion et

NetherlandsICD-10-NL

T80.8overige gespecificeerde complicaties na infusie, transfusie en therapeutische

United StatesICD-10-CM

Listed through more specific codes:

  • T80.810AExtravasation of vesicant antineoplastic chemotherapy, initial encounter
  • T80.810DExtravasation of vesicant antineoplastic chemotherapy, subsequent encounter
  • T80.810SExtravasation of vesicant antineoplastic chemotherapy, sequela
  • T80.818AExtravasation of other vesicant agent, initial encounter
  • T80.818DExtravasation of other vesicant agent, subsequent encounter
  • T80.818SExtravasation of other vesicant agent, sequela
  • T80.82XAComplication of immune effector cellular therapy, initial encounter
  • T80.82XDComplication of immune effector cellular therapy, subsequent encounter
  • and 4 more national subcodes

Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.

Look up another code

Stop looking codes up by hand

Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.

Try Docdemic free